UNSPSC 85515618: Bypass left popliteal artery to foot artery with nonautologous tissue substitute, open approach

This classification denotes the group of activities that yields a surgical intervention or procedure to bypass left popliteal artery to foot artery with nonautologous tissue substitute, open approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 041N0KP

UNSPSC 85515618 Bypass left popliteal artery to foot artery with nonautologous tissue substitute, open approach is a Commodity code that describes a specific vascular surgical procedure, but the recent state and local contract opportunities tagged under it do not reflect procurement of this clinical service. Instead, the opportunities show state and local governments soliciting medical evaluation, occupational health surveillance, pharmacy benefit management, and temporary health professional staffing — none of which align with procurement of a surgical bypass procedure or related implantable devices. The code shows little relevant recent activity; the tagging appears to reflect a systematic mismatch between the code's nominal surgical-procedure scope and the administrative and staffing health services actually being bought.

The six opportunities on file span Arizona (Phoenix Fire and Police pension boards' independent medical evaluation services, due October 16, 2026), California (City of Long Beach surgical center-of-excellence carve-out benefits and County of Santa Clara temporary health professional staffing, due October 7, 2026 for both), Washington (Washington State Department of Transportation's occupational medical surveillance, due October 9, 2026), Texas (Harris County Juvenile Probation Department emergency and inpatient services for detained youth, due September 25, 2026), and Florida (Collier County pharmacy benefit management, due April 9, 2026, with historical spend of approximately $8.7 million annually). None of these solicitations involve vascular surgery, implants, or the procedural intervention the code describes, and none represent a coherent market signal for vendors in the surgical-device or procedural-services space.